Search by conditions:


Protocol Description Phase
14-089 A Phase 1b/2 Study of Ramucirumab in Combination with LY2875358 in Patients with Advanced Cancer  (View details on Phase II
13-251 A Phase I, Gene Alteration-based, Open Label, Multicenter Study of Oral Debio 1347 (CH5183284) in Patients With Advanced Solid Malignancies, Whose Tumours Have an Alteration of the Fibroblast Growth Factor Receptor (FGFR) 1, 2 or 3 Genes  (View details on Phase I
2 clinical trials listed

Back to Top